Half-year Financial Report

Summary by AI BETAClose X

Abingdon Health plc reported a 45% increase in total revenue to £4.5 million for the six months ended December 31, 2025, with reported revenue reaching £4.2 million. The company expects the second half of fiscal year 2026 to be profitable with positive operating cash flow, and maintains its full-year revenue guidance of £12.6 million. Despite an adjusted EBITDA loss of £1.7 million in the first half due to investment in growth, the company secured new contracts, including a $2.5 million deal announced on March 12, 2026, and is confident in its outlook for fiscal year 2027. Cash and cash equivalents stood at £3.7 million as of December 31, 2025, following a £3.2 million fundraising.

Disclaimer*

UK 100

Latest directors dealings